Smoking and Lung Disease

Overview of Chronic Obstructive Pulmonary Disease (COPD)

• COPD Definition and Significance:

  • COPD stands for chronic obstructive pulmonary disease, which is an umbrella term for a group of diseases that cause airflow blockage and breathing-related problems. It's not just one disease but includes conditions such as emphysema and chronic bronchitis.

  • The definition used in this lecture reflects the United States medical system's criteria. This means that in the U.S., doctors diagnose COPD based on specific symptoms, medical history, and tests rather than using a universal definition.

  • Prevalence: COPD is among the top 10 diseases in the United States based on the number of individuals affected, meaning millions of people are living with it.

  • Mortality: It is the fourth leading cause of death in the United States, following heart disease, cancer, and accidents. The high mortality rate highlights the importance of awareness, prevention, and treatment.

• Progression and Characteristics:

  • COPD is a progressive disease, which means it worsens over time. Early symptoms may be mild and go unnoticed, leading individuals to ignore them.

  • Early stage: The onset is often so mild that individuals may not realize they have it. They might chalk it up to getting older or just being out of shape.

  • Late stage: Characterized by a noticeable shortness of breath and difficulty breathing, making routine tasks like climbing stairs or walking a distance very challenging.

  • Productive Cough: Unlike a dry cough caused by irritation, COPD is characterized by a productive cough, which means that the cough brings up mucus. This mucus is produced in response to blockages in the airways. The cough is a body's way of trying to get rid of mucus that is obstructing breathing.

Pathophysiology and Symptoms of COPD

• Cilia Loss:

  • Normal lung function involves cilia, which are small hair-like structures on cells lining the airway. These cilia have an important role in keeping the airways clean and clear.

  • Function of Cilia: They move mucus that has trapped irritants (like smoke particles) or pathogens (bacteria and viruses) out of the lungs to be swallowed, blown out, or coughed up, acting like tiny brooms.

  • Effect of Smoking: Cigarette smoke contains substances that can damage cilia, killing them off. Without healthy cilia, the lungs start to struggle with clearing out mucus, leading to blockage and increased risk of infection.

• Mucus Gland Hyperplasia:

  • Smoking causes the glands responsible for producing mucus to grow faster than normal, a process called hyperplasia. This means these glands produce too much mucus, compounding the problem created by the loss of cilia.

  • This results in the overproduction of mucus while the mechanism for removing it, the cilia, is either destroyed or less effective. This excess mucus can block air passages, making it even harder to breathe.

• Inflammation and Fibrosis:

  • Patients exhibit significant internal inflammation, which is the body's response to injury or infection, but in the case of COPD, it's chronic and harmful.

  • Airways and lungs undergo fibrosis, which refers to thickening and scarring of lung tissue. This leads to a loss of elasticity, making breathing shallow and labored since the lungs cannot expand and contract efficiently.

• Destruction of Alveoli:

  • The alveoli are tiny air sacs where gas exchange occurs. COPD involves the physical destruction of these alveoli, which severely impairs the body's ability to oxygenate blood and remove carbon dioxide.

  • Consequences: Even if oxygen enters the lungs, the damaged structure of the alveoli prevents it from being absorbed effectively into the bloodstream. Similarly, carbon dioxide ($CO_2$) cannot be efficiently transferred from the blood into the lungs for exhalation, leading to feelings of breathlessness and fatigue.

Molecular Mechanisms of Respiratory Damage

• Blockage of NRF2 Function:

  • NRF2 is a transcription factor, a type of protein that helps regulate the expression of antioxidant and anti-inflammatory genes. These genes are crucial for counteracting the harmful effects of substances like tobacco smoke.

  • Sequestration by KEAP1: Normally, a protein called KEAP1 binds to NRF2 to prevent its function, which is like an unwanted interruption. When bound, KEAP1 causes NRF2 to be marked for destruction.

  • Ubiquitination: Adding ubiquitin groups to NRF2 marks it for destruction by a cell component called the proteasome, which breaks down damaged or unneeded proteins.

  • Normal Stress Response: Under oxidative stress, such as exposure to harmful substances, KEAP1 should release NRF2. Released NRF2 moves from the cytoplasm to the nucleus of the cell to trigger antioxidant production that helps protect against damage.

  • COPD Dysfunction: In COPD, NRF2 activity is reduced, meaning the body struggles to produce the necessary antioxidants to block oxidative damage and inflammation. The exact way smoke interferes with NRF2 remains a subject of research.

• Pattern Recognition Receptors (PRRs):

  • PRRs, including Toll-like receptors, monitor for proteins that signal the presence of pathogens or cellular debris from dead cells. It's like a security system for cells.

  • Mechanism: Cigarette smoke directly causes damage in the respiratory system, leading to cell death. The debris from these dead cells activates PRRs, triggering an immune response.

  • Inflammatory Cascade: Activated PRRs release signaling molecules called interleukins which engage and activate the innate immune system. This immune response leads to airway constriction and ongoing tissue damage which is often excessive in COPD patients.

• PI3 Kinase and Accelerated Aging:

  • Smoking accelerates the natural aging process of the respiratory system, contributing to decreased elasticity and worsening alveolar function.

  • The Pathway: Oxidative stress from smoking activates a protein called PI3 kinase, which plays a role in many cell signaling processes.

  • Downstream Effects: Activated PI3 kinase triggers further proteins like AKT, which activates mTOR (a key growth regulator) and sirtuins (proteins linked to aging and cellular health).

  • End Results: This cascade of events leads to activation of the NF-kappa B ($NF-\text{kappa }B$) inflammation pathway, the activation of $p53$ (which stops cell growth and reduces the ability to repair DNA), and further involvement of molecules linked to inflammation like TNF-alpha ($TNF-\text{alpha}$), VEGF (which promotes blood vessel growth), TGF-beta ($TGF-\text{beta}$), and various interleukins.

Asthma and Secondhand Smoke Exposure

• Experimental Observations in Adult Smokers:

  • Experiments show that when adults who smoke are exposed to irritants (like allergens or cold air), they exhibit strong airway reactions due to heightened levels of IgE antibodies, which are typically associated with allergic responses.

  • IgE leads to histamine release, creating an allergic-like reaction in the airway, resulting in inflammation and constriction, making breathing difficult.

  • Real-world Connection: Despite these experimental findings, there isn't a definitive link in the general population between smoking and adult asthma diagnoses. This suggests that other factors might contribute to asthma development.

• Secondhand Smoke and Children:

  • There is a direct correlation between secondhand smoke exposure and the incidence of childhood asthma. Children who are exposed to secondhand smoke are at a greater risk of developing asthma and have poorer lung function compared to their peers.

  • Expiratory Flow Rate ($V_{max}$ of FCR): Healthy children who are not exposed to smoke show significantly higher maximum velocities in exhaling air, which means they can expel air from their lungs more effectively. In contrast, children of smokers exhibit lower lung function right from birth.

  • Asthma Severity: Children of mothers who smoke and have been diagnosed with asthma tend to experience more severe symptoms than those whose mothers do not smoke.

  • Lung Capacity ($FEV_1$): The forced expiratory volume in one second ($FEV_1$) measured in children of smokers is significantly reduced, indicating compromised lung function.

  • Bronchial Responsiveness: Interestingly, children of smoking mothers show decreased responsiveness to irritants, which means they may not constrict their airways as effectively to protect themselves from inhaling harmful chemicals. This is concerning as it suggests a potential failure of their lungs to react appropriately in dangerous situations.

Pneumonia and Influenza

• Risk and Severity of Pneumonia:

  • Studies show that smokers and non-smokers have a similar risk of catching pneumonia, which is an infection that inflames the air sacs in one or both lungs.

  • However, smokers usually experience much more severe symptoms. The infection often goes deeper into the lungs due to cilia damage and increased mucus production, allowing more pathogens to reach vulnerable areas.

• Influenza Interaction:

  • Deaths that occur from influenza are often due to secondary pneumonia infections; in other words, it's not the flu virus that directly causes death, but the pneumonia that can develop as a complication.

  • Speaker Anecdote: The lecturer recounted experiences of rapid-onset pneumonia following influenza, underlining the real-life impact of these infections.

  • Smokers have approximately twice the risk of developing pneumonia and dying from it after contracting the flu, which emphasizes the added dangers of smoking.

  • Historical Context: During the swine flu epidemic in the late 2000s, smokers were recognized as being at a higher risk of contracting the influenza virus, illustrating how smoking can worsen susceptibility to respiratory infections.

COVID-19 and Current Health Guidance

• Evolution of CDC Guidance: Initially, the CDC suggested that smokers might be at a higher risk of having more severe effects from COVID-19. Over time, due to accumulating epidemiological data, their guidance shifted.

  • The current advice states that smokers are at an increased risk of severe effects. This change emphasizes that smoking compromises lung health, thereby making it harder to combat respiratory viruses like COVID-19, even if the specifics of the underlying biological mechanisms are still being studied